Clinuvel Pharmaceuticals (CLVLF) Q3 2025 Earnings

27AugConfirmed
Q1 2024
Q3 2024
Q1 2025
Q3 2025
0.13
0.2
0.26
0.33

Details

Expected EPS
0.1841224
Actual EPS
0.28867762
Surprise EPS
0.1
Surprise Percent
+56.79%

Description

Clinuvel Pharmaceuticals (CLVLF) has reported earnings of 0.28867762 per share for Q3 2025.

0 Comments

Share your thoughts